CNBC · General

‘Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid

· By Elsa Ohlen
Story summary

Global biopharma M&A is experiencing a sharp uptick, putting the sector on track for its strongest year since the pre-pandemic peak seven years ago.

Read at CNBC

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.